- Home
- FCBC vs TERN Comparison
FCBC vs TERN Comparison
Compare FCBC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCBC
- TERN
- Stock Information
- Founded
- FCBC 1874
- TERN 2017
- Country
- FCBC United States
- TERN United States
- Employees
- FCBC N/A
- TERN N/A
- Industry
- FCBC Major Banks
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- FCBC Finance
- TERN Health Care
- Exchange
- FCBC Nasdaq
- TERN Nasdaq
- Market Cap
- FCBC 696.3M
- TERN 634.5M
- IPO Year
- FCBC 1992
- TERN 2021
- Fundamental
- Price
- FCBC $37.13
- TERN $7.23
- Analyst Decision
- FCBC
- TERN Buy
- Analyst Count
- FCBC 0
- TERN 6
- Target Price
- FCBC N/A
- TERN $13.99
- AVG Volume (30 Days)
- FCBC 38.4K
- TERN 1.2M
- Earning Date
- FCBC 10-21-2025
- TERN 11-11-2025
- Dividend Yield
- FCBC 3.31%
- TERN N/A
- EPS Growth
- FCBC N/A
- TERN N/A
- EPS
- FCBC 2.72
- TERN N/A
- Revenue
- FCBC $162,762,000.00
- TERN N/A
- Revenue This Year
- FCBC $2.27
- TERN N/A
- Revenue Next Year
- FCBC $11.13
- TERN N/A
- P/E Ratio
- FCBC $13.76
- TERN N/A
- Revenue Growth
- FCBC N/A
- TERN N/A
- 52 Week Low
- FCBC $32.81
- TERN $1.87
- 52 Week High
- FCBC $49.02
- TERN $11.00
- Technical
- Relative Strength Index (RSI)
- FCBC 46.93
- TERN 56.88
- Support Level
- FCBC $37.18
- TERN $6.78
- Resistance Level
- FCBC $38.22
- TERN $7.67
- Average True Range (ATR)
- FCBC 1.10
- TERN 0.44
- MACD
- FCBC 0.02
- TERN -0.04
- Stochastic Oscillator
- FCBC 6.93
- TERN 51.33
About FCBC First Community Bankshares Inc. (VA)
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.